Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 13%
Buy 38%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Hldgs is a dominant player in the home care industry, providing specialized care to complex patient populations and consistently driving strong financial results. Despite potential headwinds from government reimbursement and labor availability, Aveanna's expanding network of preferred payor relationships and track record of delivering consistent topline growth demonstrate its resilience and potential for continued success. With strong leadership and a commitment to compliance, Aveanna appears well-positioned to continue its growth trajectory and create value for shareholders in the years ahead.

Bears say

Aveanna Healthcare Hldgs is a differentiated provider of high-quality home healthcare, with a core focus on private-duty nursing (PDN) for children with medical complexities (CMCs), a highly regulated and stable market. While the company has a favorable regulatory backdrop and a diversified payor base, its profitability may be constrained by rising labor costs and potential compliance issues. Additionally, a majority of the company's leadership is composed of private equity and the executive management team, which may lead to conflicts of interest.

AVAH has been analyzed by 8 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 38% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 8 analysts, AVAH has a Buy consensus rating as of May 6, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $9.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $9.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.